Showing 1 - 9 of 9
Persistent link: https://www.econbiz.de/10005439226
In this article, we present the findings of a study examining the exploding problem of counterfeit trade via the opinions of U.S. executives as compared to their counterparts from Australia, New Zealand, South Africa, and Tahiti. Their responses provide insight as to how companies in different...
Persistent link: https://www.econbiz.de/10008499395
This article reports the results of personal interviews with multinational managers regarding the changing business environment in the European Union (EU). The study investigates pharmaceutical executives' perceptions of significant issues facing their industry in the EU and what types of...
Persistent link: https://www.econbiz.de/10009212665
This paper investigates the changing business environment of the pharmaceutical industry as a result of regional integration. Peggy Chaudhry, Peter Dacin and J. Paul Peter develop specific research propositions on such issues as regulated prices, Pan-European selling tactics, gray markets, and...
Persistent link: https://www.econbiz.de/10009212780
Almost every product imaginable is being copied and manufactured in China, then either sold there or exported elsewhere. While some improvement in the overall intellectual property rights (IPR) environment in China has occurred recently, the issue of piracy remains a daunting one. To understand...
Persistent link: https://www.econbiz.de/10010617280
This paper analyzes how international marketing researchers deal with cultural differences in the modern global economy. A survey was designed to examine several hypotheses related to the evolving diversification of cultural factors in a worldwide setting, given international managers’ product...
Persistent link: https://www.econbiz.de/10008459583
The recent case of fake Avastin® brought the problem of counterfeit pharmaceuticals to the forefront of illicit trade. Drug counterfeiters are opportunistic criminals motivated by the windfall profits that are realized from selling fake pharmaceuticals with limited legal penalties. This article...
Persistent link: https://www.econbiz.de/10011065236
For many decades, organizations have implemented information systems for overseeing their business processes. These information systems have developed into what are known as enterprise information systems. Overall, a key part of establishing the enterprise information system in an organization...
Persistent link: https://www.econbiz.de/10010570113
Persistent link: https://www.econbiz.de/10005326945